104 related articles for article (PubMed ID: 7121669)
1. Is the erythropoietin-hematocrit feedback control operative in chronic renal failure?
Walle AJ; Weiland E; Proppe D; Niedermayer W
Nephron; 1982; 31(3):229-35. PubMed ID: 7121669
[TBL] [Abstract][Full Text] [Related]
2. Peripheral haematocrit modulates erythropoietin production and kinetics of reticulocytes in chronic uraemic patients.
Walle A; Garcia JF; Niedermayer W
Proc Eur Dial Transplant Assoc; 1981; 18():633-7. PubMed ID: 7329990
[TBL] [Abstract][Full Text] [Related]
3. Is there a dissociation of erythropoietic proliferation and serum erythropoietin levels in renal failure patients on longterm haemodialysis treatment.
Walle AJ; Niedermayer W
Proc Eur Dial Transplant Assoc; 1980; 17():162-6. PubMed ID: 7243765
[TBL] [Abstract][Full Text] [Related]
4. Are erythropoietin levels in uraemic patients on haemodialysis dependent on the kidney disease and the duration of haemodialysis treatment?
Walle AJ; Niedermayer W
Proc Eur Dial Transplant Assoc; 1979; 16():481-6. PubMed ID: 548991
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
Sobota JT
Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
[No Abstract] [Full Text] [Related]
6. Erythropoietin-hematocrit feedback circuit in the anemia of end-stage renal disease.
Walle AJ; Wong GY; Clemons GK; Garcia JF; Niedermayer W
Kidney Int; 1987 May; 31(5):1205-9. PubMed ID: 3599659
[TBL] [Abstract][Full Text] [Related]
7. Erythropoiesis and erythropoietin in patients with chronic renal failure treated with hemodialysis and testosterone.
DeGowin RL; Lavender AR; Forland M; Charleston D; Gottschalk A
Ann Intern Med; 1970 Jun; 72(6):913-8. PubMed ID: 5448750
[No Abstract] [Full Text] [Related]
8. [Effects of testosterone and methenolone on erythropoietin activity and erythropoiesis in patients with kidney failure].
Essers U
Med Welt; 1971 Nov; 48(71):1918-9. PubMed ID: 5133162
[No Abstract] [Full Text] [Related]
9. Regulatory mechanisms of erythropoietin levels in dialysis patients.
Tagawa H; Umezu M; Saito T; Yamakado M; Nagano M; Urabe A; Takaku F
Nihon Jinzo Gakkai Shi; 1990 Mar; 32(3):297-303. PubMed ID: 2355666
[TBL] [Abstract][Full Text] [Related]
10. Red cells life span, splenic sequestration and transfusion requirements in chronic renal failure treated by hemodialysis. Effects of bilateral nephrectomy.
Laurent C; Wittek M; Vereerstraeten P; Toussaint C; Naets JP
Clin Nephrol; 1974; 2(1):35-40. PubMed ID: 4823492
[No Abstract] [Full Text] [Related]
11. Relation of serum erythropoietin levels to renal excretory function: evidence for lowered set point for erythropoietin production in chronic renal failure.
Chandra M; Clemons GK; McVicar MI
J Pediatr; 1988 Dec; 113(6):1015-21. PubMed ID: 3193306
[TBL] [Abstract][Full Text] [Related]
12. Serum immunoreactive erythropoietin levels in patients with polycystic kidney disease as compared with other hemodialysis patients.
Chandra M; Miller ME; Garcia JF; Mossey RT; McVicar M
Nephron; 1985; 39(1):26-9. PubMed ID: 3969187
[TBL] [Abstract][Full Text] [Related]
13. [The influence of testosterone on the anaemia of terminal renal failure (author's transl)].
Augustin HJ; Kapaun W; Kötter C
Dtsch Med Wochenschr; 1973 Nov; 98(45):2119-22. PubMed ID: 4757967
[No Abstract] [Full Text] [Related]
14. The anemia of chronic renal failure in sheep. Response to erythropoietin-rich plasma in vivo.
Eschbach JW; Mladenovic J; Garcia JF; Wahl PW; Adamson JW
J Clin Invest; 1984 Aug; 74(2):434-41. PubMed ID: 6746902
[TBL] [Abstract][Full Text] [Related]
15. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.
Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A
Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
[TBL] [Abstract][Full Text] [Related]
17. Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis.
Zehnder C; Blumberg A
Clin Nephrol; 1989 Feb; 31(2):55-9. PubMed ID: 2920469
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin and inhibitors of in vitro erythropoiesis in the development of anemia in children with renal disease.
McGonigle RJ; Boineau FG; Beckman B; Ohene-Frempong K; Lewy JE; Shadduck RK; Fisher JW
J Lab Clin Med; 1985 Apr; 105(4):449-58. PubMed ID: 3981057
[TBL] [Abstract][Full Text] [Related]
19. [The correction of anemia with a high requirement for transfusion in patients on maintenance hemodialysis by conventional and reduced doses of recombinant human erythropoietin].
Sivak L; Scuteri RM; Cavalli NH; Gotlieb D; López Blanco OA
Medicina (B Aires); 1992; 52(6):516-22. PubMed ID: 1340900
[TBL] [Abstract][Full Text] [Related]
20. Normalization of hematocrit in a uremic patient receiving hemodialysis: role of erythropoietin.
Chandra M; Garcia JF; Miller ME; Waldbaum RS; Bluestone PA; McVicar M
J Pediatr; 1983 Jul; 103(1):80-3. PubMed ID: 6345743
[No Abstract] [Full Text] [Related]
[Next] [New Search]
